Date: Apr 2023
Date: Apr 2023
The Market Statsville Group (MSG) publishes the new report on the "Intrauterine Devices Market Type (Nonhormonal: Copper-containing IUD, and Hormonal: Progestogen-releasing IUD), by End-User (Hospitals, Clinics, Community Health Care Centres, Others) and by Region – Global Share and Forecast to 2033
According to the Market Statsville Group (MSG), the global Intrauterine Devices market size is expected to grow at a CAGR of 10.3% from 2023 to 2033.
The Intra Uterine Devices (IUD) market is experiencing significant growth due to increased government initiatives and programs to promote family planning and population control, coupled with technological advancements. The IUD is a highly effective form of long-acting reversible contraception that has been used for many years, and it has gained popularity in recent years due to its convenience and effectiveness. The hospital segment dominates the IUD market, accounting for the largest share of the market due to the preference of hospitals for long-acting reversible contraceptives, the ease of insertion by a trained professional, and the high efficacy rates of IUDs.
The Asia Pacific region is the largest market for IUDs, with a growing number of women opting for long-acting reversible contraceptives. Increasing awareness of the benefits of family planning and contraception, coupled with government support, is driving the growth of the IUD market in the region. The IUD market is not without its challenges, however. Lack of awareness and misconceptions about IUDs, especially in developing countries, hinders the market growth. Additionally, the high cost of IUDs and the lack of insurance coverage in some regions can limit access to the device. Nonetheless, there are several opportunities for growth in the IUD market, including technological advancements such as the development of hormonal and non-hormonal copper IUDs and increasing demand for long-acting reversible contraceptives among women globally.
The overall e-commerce fraud prevention market has been segmented into type, end-user, and region.
Healthcare & Life Sciences segment is expected to grow at the highest CAGR during the forecast period. As the healthcare industry continues to move towards digitalization, there has been a significant increase in the number of online healthcare transactions, such as telemedicine consultations, online pharmacy purchases, and electronic medical records. However, this also opens up new opportunities for fraudsters to exploit vulnerabilities in the healthcare e-commerce system. To prevent fraud and protect patient data, healthcare organizations are increasingly investing in fraud prevention solutions, such as identity verification and fraud detection tools. These solutions are designed to identify fraudulent transactions in real-time and prevent them before they can cause harm.
North America is expected to witness significant growth in the Intra Uterine Devices (IUD) market during the forecast period. This can be attributed to several factors such as the increasing prevalence of unwanted pregnancies, the growing need for effective birth control methods, and the high adoption rate of IUDs in the region. Furthermore, favorable government initiatives and programs aimed at promoting family planning and controlling population growth are also expected to boost the market growth in North America. For instance, the Affordable Care Act mandates that insurance companies must cover the cost of birth control, including IUDs, which has significantly increased the accessibility and affordability of these devices. Additionally, increasing awareness about the benefits of using IUDs as a long-term contraceptive option and the growing trend of delaying pregnancy in women are expected to drive the demand for IUDs in North America.
This research report includes a study on the development and marketing strategies, along with a study on the product portfolios and winning strategies of the leading companies operating in the e-commerce fraud prevention market. It also consists of the profiles of leading companies such as Bayer AG, CooperSurgical Inc., DKT International, Eurogine, HLL Lifecare Limited, Medicines360, Merck & Co., Inc., Mylan N.V., Pfizer Inc. , Prosan International B.V., Pregna International Limited, Abviee Inc., Shandong Weigao Group Medical Polymer Company Limited, and Teva Pharmaceutical Industries Ltd. The key players' growing research and development activities for developing innovative solutions are expected to drive market growth.
About Market Statsville Group
Market Statsville Group (MSG) is a business research and consulting platform of Statsville Consulting Private Limited, based in Oklahoma, USA. MSG is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and intelligent business insights. MSG has experienced research analysts who are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact. Furthermore, Market Statsville Group already benefited more than 1,000 companies each year for their revenue planning. It helped them take their disruptions/innovations early to the market by providing them research ahead of the curve.
MSG has an entire repository of research reports on more than 1,000 niche industries, 3,000 high-growth potentials markets, 5,000 data sets, and more than 12,000 company profiles.
Contact Us:
Market Statsville Group
800 Third Avenue Suite A #1519
New York, US 10022
USA: +1 646-663-5829 | +91 702 496 8807
Email: sales@marketstatsville.com
Web: www.marketstatsville.com
Want to Review Complete Market Research Report